<?xml version="1.0" encoding="UTF-8"?>
<p id="para0012">Given the high mortality rate, it is important to identify and address modifiable risk factors in an attempt to prevent the occurrence of candidaemia. Firstly, all our patients received broad-spectrum antibacterials, a recognized risk factor for candidaemia (
 <xref rid="bib0005" ref-type="bibr">5</xref>,
 <xref rid="bib0006" ref-type="bibr">6</xref>). A recent study from Hughes et al (
 <xref rid="bib0007" ref-type="bibr">7</xref>) demonstrated a low frequency (3.2%) of early bacterial co-infection in patients hospitalized with COVID-19, suggesting early broad-spectrum antibacterials may not be warranted. Hence, antimicrobial stewardship initiatives to review unnecessary antibacterial use remain important.
</p>
